Literature DB >> 18650345

Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration.

Hui-Ming Gao1, Paul T Kotzbauer, Kunihiro Uryu, Susan Leight, John Q Trojanowski, Virginia M-Y Lee.   

Abstract

alpha-Synuclein (SYN) is the major component of Lewy bodies, the neuropathological hallmarks of Parkinson's disease (PD). Missense mutations and multiplications of the SYN gene cause autosomal dominant inherited PD. Thus, SYN is implicated in the pathogenesis of PD. However, the mechanism whereby SYN promotes neurodegeneration remains unclear. Familial PD with SYN gene mutations are rare because the majority of PD is sporadic and emerging evidence indicates that sporadic PD may result from genetic and environmental risk factors including neuroinflammation. Hence, we examined the relationship between SYN dysfunction and neuroinflammation in mediating dopaminergic neurodegeneration in mice and dopaminergic neuronal cultures derived from wild-type SYN and mutant A53T SYN transgenic mice in a murine SYN-null (SYNKO) background (M7KO and M83KO, respectively). Stereotaxic injection of an inflammagen, lipopolysaccharide, into substantia nigra of these SYN genetically engineered mice induced similar inflammatory reactions. In M7KO and M83KO, but not in SYNKO mice, the neuroinflammation was associated with dopaminergic neuronal death and the accumulation of insoluble aggregated SYN as cytoplasmic inclusions in nigral neurons. Nitrated/oxidized SYN was detected in these inclusions and abatement of microglia-derived nitric oxide and superoxide provided significant neuroprotection in neuron-glia cultures from M7KO mice. These data suggest that nitric oxide and superoxide released by activated microglia may be mediators that link inflammation and abnormal SYN in mechanisms of PD neurodegeneration. This study advances understanding of the role of neuroinflammation and abnormal SYN in the pathogenesis of PD and opens new avenues for the discovery of more effective therapies for PD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18650345      PMCID: PMC2702093          DOI: 10.1523/JNEUROSCI.0143-07.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  81 in total

Review 1.  Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studies.

Authors:  Caroline M Tanner
Journal:  Adv Neurol       Date:  2003

2.  Selective microglial activation in the rat rotenone model of Parkinson's disease.

Authors:  Todd B Sherer; Ranjita Betarbet; Jin Ho Kim; J Timothy Greenamyre
Journal:  Neurosci Lett       Date:  2003-05-01       Impact factor: 3.046

3.  Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.

Authors:  William Dauer; Nikolai Kholodilov; Miquel Vila; Anne-Cecile Trillat; Rose Goodchild; Kristin E Larsen; Roland Staal; Kim Tieu; Yvonne Schmitz; Chao Annie Yuan; Marcelo Rocha; Vernice Jackson-Lewis; Steven Hersch; David Sulzer; Serge Przedborski; Robert Burke; Rene Hen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-10       Impact factor: 11.205

4.  Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration.

Authors:  Amy B Manning-Bog; Alison L McCormack; Maya G Purisai; Laurel M Bolin; Donato A Di Monte
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

5.  Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease.

Authors:  Hui-Ming Gao; Jau-Shyong Hong; Wanqin Zhang; Bin Liu
Journal:  J Neurosci       Date:  2003-02-15       Impact factor: 6.167

6.  Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease.

Authors:  Deniz Kirik; Lucy E Annett; Corinna Burger; Nicholas Muzyczka; Ronald J Mandel; Anders Björklund
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

7.  alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.

Authors:  C Lo Bianco; J-L Ridet; B L Schneider; N Deglon; P Aebischer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

Review 8.  Role of nitric oxide in inflammation-mediated neurodegeneration.

Authors:  Bin Liu; Hui-Ming Gao; Jiz-Yuh Wang; Gwang-Ho Jeohn; Cynthia L Cooper; Jau-Shyong Hong
Journal:  Ann N Y Acad Sci       Date:  2002-05       Impact factor: 5.691

9.  Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.

Authors:  Edward Rockenstein; Margaret Mallory; Makoto Hashimoto; David Song; Clifford W Shults; Ingrid Lang; Eliezer Masliah
Journal:  J Neurosci Res       Date:  2002-06-01       Impact factor: 4.164

10.  Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease.

Authors:  Hui-Ming Gao; Janwei Jiang; Belinda Wilson; Wanqin Zhang; Jau-Shyong Hong; Bin Liu
Journal:  J Neurochem       Date:  2002-06       Impact factor: 5.372

View more
  177 in total

1.  Confident identification of 3-nitrotyrosine modifications in mass spectral data across multiple mass spectrometry platforms.

Authors:  Bensheng Li; Jason M Held; Birgit Schilling; Steven R Danielson; Bradford W Gibson
Journal:  J Proteomics       Date:  2011-04-15       Impact factor: 4.044

2.  Being too inclusive about synuclein inclusions.

Authors:  Ole Isacson; Ivar Mendez
Journal:  Nat Med       Date:  2010-09       Impact factor: 53.440

3.  Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice.

Authors:  Haeman Jang; David Boltz; Jennifer McClaren; Amar K Pani; Michelle Smeyne; Ane Korff; Robert Webster; Richard Jay Smeyne
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

Review 4.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

Review 5.  The executioners sing a new song: killer caspases activate microglia.

Authors:  J L Venero; M A Burguillos; P Brundin; B Joseph
Journal:  Cell Death Differ       Date:  2011-08-12       Impact factor: 15.828

6.  Non-cell autonomous cell death caused by transmission of Huntingtin aggregates in Drosophila.

Authors:  Daniel T Babcock; Barry Ganetzky
Journal:  Fly (Austin)       Date:  2015       Impact factor: 2.160

Review 7.  Immune-mediated processes in neurodegeneration: where do we stand?

Authors:  Marc Fakhoury
Journal:  J Neurol       Date:  2016-02-12       Impact factor: 4.849

Review 8.  Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.

Authors:  Georgia S Gaki; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2014-02-13       Impact factor: 3.843

Review 9.  Parkinson's disease and enhanced inflammatory response.

Authors:  Iva Stojkovska; Brandon M Wagner; Brad E Morrison
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

10.  Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse.

Authors:  Mari H Savolainen; Katrina Albert; Mikko Airavaara; Timo T Myöhänen
Journal:  Exp Brain Res       Date:  2017-04-24       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.